POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]
- RxCUI
- 1718990
- RxNorm name
- POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]
- Display name
- POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]
- Full name
- POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GaviLyte-H and Bisacodyl | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL DELAYED-RELEASE TABLET | Lupin Pharmaceuticals, Inc. | 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3 | 2025-01-28 | Warnings, Adverse reactions | 1718990 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3 | POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H] | SY | 3 | These highlights do not include all the information needed to use GaviLyte-H and Bisacodyl safely and effectively. See full prescribing information for GaviLyte-H and Bisacodyl. GaviLyte-H and Bisacodyl (Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed release Tablet) KIT for ORAL use. Initial U.S. Approval: 2004 | 20250128 |
| 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3 | Gavilyte-H Powder for Oral Solution | PSN | 3 | These highlights do not include all the information needed to use GaviLyte-H and Bisacodyl safely and effectively. See full prescribing information for GaviLyte-H and Bisacodyl. GaviLyte-H and Bisacodyl (Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed release Tablet) KIT for ORAL use. Initial U.S. Approval: 2004 | 20250128 |
| 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3 | Gavilyte-H Powder for Oral Solution | SY | 3 | These highlights do not include all the information needed to use GaviLyte-H and Bisacodyl safely and effectively. See full prescribing information for GaviLyte-H and Bisacodyl. GaviLyte-H and Bisacodyl (Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed release Tablet) KIT for ORAL use. Initial U.S. Approval: 2004 | 20250128 |
| 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3 | polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution [Gavilyte-H] | SBD | 3 | These highlights do not include all the information needed to use GaviLyte-H and Bisacodyl safely and effectively. See full prescribing information for GaviLyte-H and Bisacodyl. GaviLyte-H and Bisacodyl (Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed release Tablet) KIT for ORAL use. Initial U.S. Approval: 2004 | 20250128 |
| 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3 | POLYETHYLENE GLYCOL 3350 210000 MG / K+ Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H] | SY | 3 | These highlights do not include all the information needed to use GaviLyte-H and Bisacodyl safely and effectively. See full prescribing information for GaviLyte-H and Bisacodyl. GaviLyte-H and Bisacodyl (Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed release Tablet) KIT for ORAL use. Initial U.S. Approval: 2004 | 20250128 |